CEA, CNRS, Laboratoire des Maladies Neurodégénératives, MIRCen, Université Paris-Saclay, 18 Route du Panorama, 92265, Fontenay-aux-Roses, France.
Direction de la Recherche Fondamentale (DRF), Institut François Jacob, MIRCen, Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), 18 Route du Panorama, 92265, Fontenay-aux-Roses, France.
Acta Neuropathol Commun. 2022 Aug 16;10(1):112. doi: 10.1186/s40478-022-01410-y.
Alzheimer's disease (AD) is characterized by intracerebral accumulations of extracellular amyloid-β (Aβ) plaques and intracellular tau pathology that spread in the brain. Three types of tau lesions occur in the form of neuropil threads, neurofibrillary tangles, and neuritic plaques i.e. tau aggregates within neurites surrounding Aβ deposits. The cascade of events linking these lesions and synaptic or memory impairments are still debated. Intracerebral infusion of human AD brain extracts in Aβ plaque-bearing mice that do not overexpress pathological tau proteins induces tau pathologies following heterotopic seeding of mouse tau protein. There is however little information regarding the downstream events including synaptic or cognitive repercussions of tau pathology induction in these models. In the present study, human AD brain extracts (AD) and control-brain extracts (Ctrl) were infused into the hippocampus of Aβ plaque-bearing APP/PS1 mice. Memory, synaptic density, as well as Aβ plaque and tau aggregate loads, microgliosis, astrogliosis at the inoculation site and in connected regions (perirhinal/entorhinal cortex) were evaluated 4 and 8 months post-inoculation. AD inoculation produced the following effects: (i) memory deficit; (ii) increased Aβ plaque deposition in proximity to the inoculation site; (iii) tau pathology induction; (iv) appearance of neuropil threads and neurofibrillary tangles next to the inoculation site with a spreading to connected regions. Neuritic plaque pathology was detected in both AD- and Ctrl-inoculated animals but AD inoculation increased the severity close to and at distance of the inoculation site. (v) Finally, AD inoculation reduced synaptic density in the vicinity to the inoculation site and in connected regions as the perirhinal/entorhinal cortex. Synaptic impairments were correlated with increased severity of neuritic plaques but not to other tau lesions or Aβ lesions, suggesting that neuritic plaques are a culprit for synaptic loss. Synaptic density was also associated with microglial load.
阿尔茨海默病(AD)的特征是脑内细胞外淀粉样β(Aβ)斑块和细胞内 tau 病理学的积累,这些病理学在大脑中扩散。tau 病变有三种类型,表现为神经原纤维缠结、神经纤维缠结和神经原纤维缠结,即神经突起内的 tau 聚集物围绕着 Aβ 沉积物。将这些病变与突触或记忆损伤联系起来的级联事件仍存在争议。在不过度表达病理性 tau 蛋白的 Aβ 斑块携带小鼠中,脑内输注人类 AD 脑提取物会诱导 tau 病理学,随后会出现鼠 tau 蛋白的异位播种。然而,关于这些模型中 tau 病理学诱导的下游事件,包括突触或认知反应,信息很少。在本研究中,将人类 AD 脑提取物(AD)和对照脑提取物(Ctrl)输注到 Aβ 斑块携带的 APP/PS1 小鼠的海马体中。在接种后 4 和 8 个月评估记忆、突触密度以及 Aβ 斑块和 tau 聚集物负荷、小胶质细胞增生、接种部位和连接区域(旁海马/内嗅皮层)的星形胶质细胞增生。AD 接种产生了以下影响:(i)记忆缺陷;(ii)接种部位附近 Aβ 斑块沉积增加;(iii)tau 病理学诱导;(iv)接种部位附近出现神经原纤维缠结和神经纤维缠结,向连接区域扩散。在 AD 和 Ctrl 接种的动物中都检测到神经原纤维缠结病理学,但 AD 接种增加了接种部位附近和远处的严重程度。(v)最后,AD 接种减少了接种部位附近和连接区域(如旁海马/内嗅皮层)的突触密度。突触损伤与神经原纤维缠结的严重程度相关,但与其他 tau 病变或 Aβ 病变无关,这表明神经原纤维缠结是突触丢失的罪魁祸首。突触密度还与小胶质细胞负荷相关。